0
0

TEST Act of 2022

3/13/2024, 7:48 AM

Congressional Summary of S 5167

Temporary Emergency Scheduling and Testing of Fentanyl Analogues Act of 2022 or the TEST Act of 2022

This bill (1) extends the temporary scheduling of fentanyl-related substances in schedule I of the Controlled Substances Act for two years; (2) requires the Drug Enforcement Administration to submit synthetic compounds of fentanyl-related substances it has encountered thus far to the Food and Drug Administration for scientific and medical evaluations, if they have not yet been evaluated; and (3) provides for the removal and rescheduling of fentanyl-related substances from schedule I if certain criteria are met, as well as notifications about any such scheduling changes to individuals who were or are being prosecuted for offenses related to such substances.

Current Status of Bill S 5167

Bill S 5167 is currently in the status of Bill Introduced since December 1, 2022. Bill S 5167 was introduced during Congress 117 and was introduced to the Senate on December 1, 2022.  Bill S 5167's most recent activity was Referred to the Committee on the Judiciary. as of December 1, 2022

Bipartisan Support of Bill S 5167

Total Number of Sponsors
1
Democrat Sponsors
1
Republican Sponsors
0
Unaffiliated Sponsors
0
Total Number of Cosponsors
0
Democrat Cosponsors
0
Republican Cosponsors
0
Unaffiliated Cosponsors
0

Policy Area and Potential Impact of Bill S 5167

Primary Policy Focus

Crime and Law Enforcement

Alternate Title(s) of Bill S 5167

TEST Act of 2022
TEST Act of 2022
Temporary Emergency Scheduling and Testing of Fentanyl Analogues Act of 2022
A bill to extend the temporary order for fentanyl-related substances.

Comments